Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925868 · ClinicalTrials.gov registry record · NA
The Mental Health Effects of a Mindfulness App in Parents of a Child With Medical Complexity
A NA study, sponsored by Boise State University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT05925868: Completed NA study, sponsored by Boise State University.
NCT05925868 is a NA study that has completed, run by Boise State University. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05925868, a NA study, has completed, sponsored by Boise State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The number of children with special health care needs (CSHCN) in the US is nearly 20% of children representing approximately 14.6 million children nationally. A subgroup of CSHCN are children who have the most intensive healthcare needs known as children with a medical complexity (CMC). Parents of CMC experience many challenges. In addition to typical caregiver tasks, parents of a CMC may experience added stress and are more likely to experience higher rates of anxiety, depression, and post-traumatic stress disorder than parents of healthy children. This project aims to explore the acceptability and feasibility of a mindfulness mobile application for parents of a CMC as well as determine the effectiveness of mindfulness application use on stress, depression, and family management in parents of a CMC. Forty-five participants will be recruited and given access to a mindfulness application and instructed to use it at least 4 days a week for at least 10 minutes. Parents will fill out questionnaires on app usage, as well as stress, depression, and family management. This work will be accomplished through a pilot single arm approach.
Primary Outcome
The feasibility scale will be used to assess the feasibility of the app during and after the study. This is based on a questionnaire by Rung, Oral, Berghammer, Peters (2020)35. It consists of closed-ended and open-ended questions that ask parents to rate the app, whether they would recommend it, and asks about their experience using the app and whether they intend to continue its use.
Interventions
- BEHAVIORAL mindfulness app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-11-23 |
| Phase | NA |
What the finished NCT05925868 record still lists
NCT05925868 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which mindfulness app is the first listed.
NCT05925868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05925868 about?
NCT05925868 is a clinical study titled "The Mental Health Effects of a Mindfulness App in Parents of a Child With Medical Complexity". The number of children with special health care needs (CSHCN) in the US is nearly 20% of children representing approximately 14.6 million children nationally. A subgroup of CSHCN are children who have the most intensive healthcare needs known as children with a medical complexity (CMC). Parents of C...
What is the current status of trial NCT05925868?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2023-02-01. Estimated completion is 2023-11-23.
What interventions are being tested in trial NCT05925868?
The interventions under investigation include: mindfulness app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05925868?
This trial is sponsored by Boise State University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05925868's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI